tiprankstipranks
Advertisement
Advertisement
Sionna Therapeutics downgraded to Hold from Buy at Freedom Broker
PremiumThe FlySionna Therapeutics downgraded to Hold from Buy at Freedom Broker
2M ago
Sionna Therapeutics price target raised to $55 from $44 at Stifel
Premium
The Fly
Sionna Therapeutics price target raised to $55 from $44 at Stifel
3M ago
Citizens biotechnology analyst holds analyst/industry conference call
Premium
The Fly
Citizens biotechnology analyst holds analyst/industry conference call
3M ago
Sionna Therapeutics price target raised to $63 from $52 at JonesResearch
PremiumThe FlySionna Therapeutics price target raised to $63 from $52 at JonesResearch
3M ago
Three new option listings on March 17th
Premium
The Fly
Three new option listings on March 17th
5M ago
SION Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SION Earnings this Week: How Will it Perform?
5M ago
Sionna Therapeutics reports Q4 EPS (46c), consensus (55c)
PremiumThe FlySionna Therapeutics reports Q4 EPS (46c), consensus (55c)
5M ago
Sionna Therapeutics initiated with an Outperform at Citizens
Premium
The Fly
Sionna Therapeutics initiated with an Outperform at Citizens
5M ago
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
Premium
Ratings
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100